Company
Geron Corporation
Geron Corporation has 5 drugs tracked on RxWires: 1 in Phase 3, 1 in Phase 2, 3 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Imetelstat | Phase 3 | Myelofibrosis |
| Imetelstat 4.7 mg/kg | Phase 2 | Myelofibrosis |
| Biospecimen Collection | Phase 1 | Recurrent Childhood Acute Myeloid Leukemia |
| GRN163L | Phase 1 | Chronic Lymphoproliferative Diseases |
| GRN163L in combination with trastuzumab | Phase 1 | Breast Neoplasms |
Latest
- geron corporation filed 8-K
- geron corporation filed 8-K
- geron corporation filed 8-K
- geron corporation filed 8-K
- geron corporation filed 8-K
Follow Geron Corporation on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.